YOKNEAM ILIT, Israel, Nov. 27, 2024 /PRNewswire/ -- PixCell Medical, a leading innovator in point-of-care diagnostics, proudly announces that its groundbreaking HemoScreen CBC analyzer has achieved ...

The HemoScreen device is FDA cleared to perform the Complete Blood Count (CBC), which can be used at the point of testing. A device produced by the Israeli company PixCell was selected for a research ...

YOKNEAM ILIT, Israel – January 11, 2021 - PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, today announced a partnership with Triolab, the largest diagnostics distributor ...

YOKNEAM ILLIT, Israel, Nov. 29, 2023 /PRNewswire/ -- A groundbreaking study conducted by a University of North Carolina (UNC) research team has unveiled compelling evidence supporting the adoption of ...

YOKNEAM ILIT, Israel, Oct. 5, 2020 /PRNewswire/ -- PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that it has received regulatory approval from the ...

Clinics, urgent care centers, busy hospitals, and patients can count on Hemoscreen, a miniaturized point-of-care hematology analyzer made by Pixcell Medical Technologies Ltd., to provide accurate ...

Soulbrain Holdings Co. Ltd. ramped up its unusual diversification program with the acquisition of Pixcell Medical Technologies Ltd. as part of the semiconductor company's shift into health care and in ...